<?xml version="1.0" encoding="UTF-8"?>
<p id="par0120">Remdesivir is an antiviral agent that binds to the active site on RdRp has broad-spectrum activities against viruses including EBOLAV, MERS-CoV, and SARS-CoV with controversial results and in the absence of reported cardiovascular toxicity. It was the first drug used in SARS-CoV2. Clinical trials have shown no cytotoxicity or adverse reactions related [
 <xref rid="bib0255" ref-type="bibr">[51]</xref>, 
 <xref rid="bib0260" ref-type="bibr">[52]</xref>, 
 <xref rid="bib0265" ref-type="bibr">[53]</xref>, 
 <xref rid="bib0270" ref-type="bibr">[54]</xref>].
</p>
